author-photo

Rehiana Ali

Imperial College London

12

Papers

185

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.

2021 Lancet Neurology
Show All
- Source
- Cite
- Save
Citations (1)
Defective CD19+CD24hiCD38hi transitional B-cell function in patients with relapsing-remitting MS.

2020 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (3)
The biology of mesenchymal stem cells and the utility of the cellular therapy in Multiple Sclerosis

2019
- Rehiana Ali
Show All
- Source
- Cite
- Save
Citations (0)
173 Outcome in a highly active multiple sclerosis cohort in the UK

2019 Journal of Neurology, Neurosurgery, and Psychiatry
Show All
- Source
- Cite
- Save
Citations (0)
Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions

2017 NeuroImage: Clinical
Show All
- Source
- Cite
- Save
Citations (17)
Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein–Barr virus

2017 Immunology
Show All
- Source
- Cite
- Save
Citations (17)
A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple Sclerosis.

2017 Journal of Neuroimaging
Show All
- Source
- Cite
- Save
Citations (27)
STREAMS: PRELIMINARY RESULTS FROM A PHASE II TRIAL

2014 Journal of Neurology, Neurosurgery, and Psychiatry
Show All
- Source
- Cite
- Save
Citations (0)
STREAMS: A Phase 2 Clinical Trial Of Autologous Mesenchymal Stem Cells In Active Multiple Sclerosis (S23.005)

2014 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Drugs in Development for Relapsing Multiple Sclerosis

2013 Drugs
Show All
- Source
- Cite
- Save
Citations (46)